首页> 美国卫生研究院文献>Elsevier Sponsored Documents >Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017
【2h】

Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015–2017

机译:全球疫苗的犹豫不决:对WHO / UNICEF联合报告表格数据2015-2017三年的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In order to gather a global picture of vaccine hesitancy and whether/how it is changing, an analysis was undertaken to review three years of data available as of June 2017 from the WHO/UNICEF Joint Report Form (JRF) to determine the reported rate of vaccine hesitancy across the globe, the cited reasons for hesitancy, if these varied by country income level and/or by WHO region and whether these reasons were based upon an assessment. The reported reasons were classified using the Strategic Advisory Group of Experts (SAGE) on Immunization matrix of hesitancy determinants (). Hesitancy was common, reported by >90% of countries. The list of cited reasons was long and covered 22 of 23 WHO determinants matrix categories. Even the most frequently cited category, risk- benefit (scientific evidence e.g. vaccine safety concerns), accounted for less than one quarter of all reasons cited. The reasons varied by country income level, by WHO region and over time and within a country. Thus based upon this JRF data, across the globe countries appear to understand the SAGE vaccine hesitancy definition and use it to report reasons for hesitancy. However, the rigour of the cited reasons could be improved as only just over 1/3 of countries reported that their reasons were assessment based, the rest were opinion based. With respect to any assessment in the previous five years, upper middle income countries were the least likely to have done an assessment. These analyses provided some of the evidence for the 2017 Assessment Report of the Global Vaccine Action Plan recommendation that each country develop a strategy to increase acceptance and demand for vaccination, which should include ongoing community engagement and trust-building, active hesitancy prevention, regular national assessment of vaccine concerns, and crisis response planning ().
机译:为了了解疫苗犹豫情况及其是否/如何变化的全球情况,我们进行了分析以审查截至2017年6月WHO / UNICEF联合报告表(JRF)可获得的三年数据,以确定报告的疫苗犹豫率。全球疫苗犹豫情况,所列举的犹豫原因(如果这些因国家收入水平和/或WHO区域而异,以及这些原因是否基于评估)。使用犹豫决定因素免疫矩阵的战略咨询专家组(SAGE)对报告的原因进行了分类。超过90%的国家/地区对此表示犹豫。列举原因的清单很长,涵盖了23个WHO决定因素矩阵类别中的22个。即使是最常被引用的类别,即风险收益(科学证据,例如疫苗安全性问题),也只占被引用所有原因的不到四分之一。原因因国家收入水平,世卫组织区域以及一段时间内和国家内部而异。因此,基于此JRF数据,全球各地的国家似乎都了解SAGE疫苗的犹豫定义,并使用它来报告犹豫的原因。但是,可以改进所引用原因的严格性,因为只有1/3以上的国家报告其原因是基于评估的,其余国家是基于意见的。就过去五年中的任何评估而言,中高收入国家最不可能进行评估。这些分析为《 2017年全球疫苗行动计划》评估报告的建议提供了一些证据,该建议建议每个国家制定一项战略以提高对疫苗接种的接受度和需求量,其中应包括持续的社区参与和建立信任,积极的犹豫预防,定期的国家预防接种,疫苗问题评估和危机应对计划()。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号